414 related articles for article (PubMed ID: 16137432)
41. Response to neoadjuvant chemotherapy in the breast predicts axillary nodal status.
Colfry AJ; Zhang X; Fuhrman GM
Am Surg; 2012 Jun; 78(6):693-7. PubMed ID: 22643266
[TBL] [Abstract][Full Text] [Related]
42. Primary chemotherapy or hormonotherapy for patients with breast cancer.
Brain EG; Misset JL; Rouëss J
Cancer Treat Rev; 1999 Aug; 25(4):187-97. PubMed ID: 10448127
[TBL] [Abstract][Full Text] [Related]
43. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
[TBL] [Abstract][Full Text] [Related]
44. Neoadjuvant chemotherapy for operable breast cancer.
Green M; Hortobagyi GN
Oncology (Williston Park); 2002 Jul; 16(7):871-84, 889; discussion 889-90, 892-4, 897-8. PubMed ID: 12164555
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy: updates and new perspectives.
Swain SM
Oncologist; 2010; 15 Suppl 5():8-17. PubMed ID: 21138951
[TBL] [Abstract][Full Text] [Related]
46. Evidence-based neoadjuvant endocrine therapy for breast cancer.
Dienstmann R; Bines J
Clin Breast Cancer; 2006 Oct; 7(4):315-20. PubMed ID: 17092398
[TBL] [Abstract][Full Text] [Related]
47. Trends in recommendations of myelosuppressive chemotherapy for the treatment of breast cancer: evolution of the national comprehensive cancer network guidelines and the cooperative group studies.
Rivera E; Smith RE
Clin Breast Cancer; 2006 Apr; 7(1):33-41. PubMed ID: 16764742
[TBL] [Abstract][Full Text] [Related]
48. A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.
Connolly R; Stearns V
Oncology (Williston Park); 2010 Feb; 24(2):135-43. PubMed ID: 20361464
[TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?
Hayes DF; Schott AF
J Natl Cancer Inst Monogr; 2015 May; 2015(51):36-9. PubMed ID: 26063884
[TBL] [Abstract][Full Text] [Related]
50. [The development of neoadjuvant chemotherapy in breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 2012 Jun; 39(6):876-81. PubMed ID: 22705682
[TBL] [Abstract][Full Text] [Related]
51. Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response.
Jones RL; Smith IE
Lancet Oncol; 2006 Oct; 7(10):869-74. PubMed ID: 17012049
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review.
Trudeau M; Sinclair SE; Clemons M;
Cancer Treat Rev; 2005 Jun; 31(4):283-302. PubMed ID: 15916855
[TBL] [Abstract][Full Text] [Related]
53. Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer.
Akyurek S; Yavas G
Exp Oncol; 2013 Dec; 35(4):267-71. PubMed ID: 24382436
[TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant therapy for breast cancer.
Zardavas D; Piccart M
Annu Rev Med; 2015; 66():31-48. PubMed ID: 25386936
[TBL] [Abstract][Full Text] [Related]
55. Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
Read RL; Flitcroft K; Snook KL; Boyle FM; Spillane AJ
ANZ J Surg; 2015 May; 85(5):315-20. PubMed ID: 25612239
[TBL] [Abstract][Full Text] [Related]
56. [Neoadjuvant treatment of early breast cancer: new drugs contribution].
Giacchetti S; Cuvier C; Hocini H; Bourstyn E; de Roquancourt A; Espié M
Bull Cancer; 2004 Dec; 91 Suppl 4():S232-8. PubMed ID: 15899614
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: equivalent outcomes?
Smith BL
Ann Surg; 2013 Feb; 257(2):180-1. PubMed ID: 23291659
[No Abstract] [Full Text] [Related]
58. Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer.
Mamounas EP
Ann Surg Oncol; 2015 May; 22(5):1425-33. PubMed ID: 25727558
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant chemotherapy for operable breast cancer: is this the future?
Mamounas EP
Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S10-9. PubMed ID: 12756074
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant therapy as a platform for drug development and approval in breast cancer.
Bardia A; Baselga J
Clin Cancer Res; 2013 Dec; 19(23):6360-70. PubMed ID: 24298066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
